Prostate cancer risk and serum levels of insulin and leptin: A population-based study

Ann W. Hsing, Streamson C. Chua, Jr., Yu Tang Gao, Elisabeth Gentzschein, Lilly Chang, Jie Deng, Frank Z. Stanczyk

Research output: Contribution to journalArticle

244 Citations (Scopus)

Abstract

Background: In a previous study of Chinese men, we found that men with a higher waist-to-hip ratio (WHR) have a higher prostate cancer risk. Because leptin and insulin are related to body fat distribution, we examined whether leptin and insulin were associated with prostate cancer risk. Methods: Blood samples were collected from 128 case patients with incident prostate cancer and from 306 healthy control subjects randomly selected from residents of Shanghai, China. Epidemiologic information and anthropometric measurements were collected in personal interviews. Serum leptin, insulin, and sex hormone levels were measured by radioimmunoassay, and insulin-like growth factor-I (IGF-I) was measured by enzyme-linked immunosorbent assay. Multiple logistic regression analyses were used to estimate odds ratios for prostate cancer in relation to serum insulin and leptin levels. All statistical tests were two-sided. Results: After adjustment for body mass index, WHR, IGF-I, and sex hormone levels, higher serum insulin levels were associated with a statistically significantly elevated risk of prostate cancer (P<.001). Men in the highest tertile of insulin levels had a 2.56-fold (95% confidence interval [CI] = 1.38 to 4.75) risk of prostate cancer compared with men in the lowest tertile. Regardless of the tertile level of WHR, higher serum insulin levels were associated with an increased risk of prostate cancer: Men in the highest tertiles of WHR (>0.900) and insulin (>8.83 μU/mL) had 8.55 times (95% CI = 2.80 to 26.10) the prostate cancer risk of men in the lowest tertiles of both, and those in the lowest tertiles of WHR (<0.873) and highest tertile of insulin had 4.30 times (95% CI = 1.17 to 15.70) the risk. By contrast, the association between leptin levels and prostate cancer risk was not statistically significant. Conclusion: Our results suggest that serum insulin levels may influence the risk of prostate cancer in Chinese men. Further research, especially prospective studies, is needed to confirm these findings in high-risk populations and to clarify the underlying mechanisms involved.

Original languageEnglish (US)
Pages (from-to)783-789
Number of pages7
JournalJournal of the National Cancer Institute
Volume93
Issue number10
StatePublished - May 16 2001
Externally publishedYes

Fingerprint

Leptin
Prostatic Neoplasms
Insulin
Serum
Population
Waist-Hip Ratio
Gonadal Steroid Hormones
Insulin-Like Growth Factor I
Body Fat Distribution
Radioimmunoassay
China
Healthy Volunteers
Body Mass Index
Logistic Models
Enzyme-Linked Immunosorbent Assay
Odds Ratio
Regression Analysis
Prospective Studies
Interviews
Research

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hsing, A. W., Chua, Jr., S. C., Gao, Y. T., Gentzschein, E., Chang, L., Deng, J., & Stanczyk, F. Z. (2001). Prostate cancer risk and serum levels of insulin and leptin: A population-based study. Journal of the National Cancer Institute, 93(10), 783-789.

Prostate cancer risk and serum levels of insulin and leptin : A population-based study. / Hsing, Ann W.; Chua, Jr., Streamson C.; Gao, Yu Tang; Gentzschein, Elisabeth; Chang, Lilly; Deng, Jie; Stanczyk, Frank Z.

In: Journal of the National Cancer Institute, Vol. 93, No. 10, 16.05.2001, p. 783-789.

Research output: Contribution to journalArticle

Hsing, AW, Chua, Jr., SC, Gao, YT, Gentzschein, E, Chang, L, Deng, J & Stanczyk, FZ 2001, 'Prostate cancer risk and serum levels of insulin and leptin: A population-based study', Journal of the National Cancer Institute, vol. 93, no. 10, pp. 783-789.
Hsing, Ann W. ; Chua, Jr., Streamson C. ; Gao, Yu Tang ; Gentzschein, Elisabeth ; Chang, Lilly ; Deng, Jie ; Stanczyk, Frank Z. / Prostate cancer risk and serum levels of insulin and leptin : A population-based study. In: Journal of the National Cancer Institute. 2001 ; Vol. 93, No. 10. pp. 783-789.
@article{fd0063da90b4451680979142e275f00c,
title = "Prostate cancer risk and serum levels of insulin and leptin: A population-based study",
abstract = "Background: In a previous study of Chinese men, we found that men with a higher waist-to-hip ratio (WHR) have a higher prostate cancer risk. Because leptin and insulin are related to body fat distribution, we examined whether leptin and insulin were associated with prostate cancer risk. Methods: Blood samples were collected from 128 case patients with incident prostate cancer and from 306 healthy control subjects randomly selected from residents of Shanghai, China. Epidemiologic information and anthropometric measurements were collected in personal interviews. Serum leptin, insulin, and sex hormone levels were measured by radioimmunoassay, and insulin-like growth factor-I (IGF-I) was measured by enzyme-linked immunosorbent assay. Multiple logistic regression analyses were used to estimate odds ratios for prostate cancer in relation to serum insulin and leptin levels. All statistical tests were two-sided. Results: After adjustment for body mass index, WHR, IGF-I, and sex hormone levels, higher serum insulin levels were associated with a statistically significantly elevated risk of prostate cancer (P<.001). Men in the highest tertile of insulin levels had a 2.56-fold (95{\%} confidence interval [CI] = 1.38 to 4.75) risk of prostate cancer compared with men in the lowest tertile. Regardless of the tertile level of WHR, higher serum insulin levels were associated with an increased risk of prostate cancer: Men in the highest tertiles of WHR (>0.900) and insulin (>8.83 μU/mL) had 8.55 times (95{\%} CI = 2.80 to 26.10) the prostate cancer risk of men in the lowest tertiles of both, and those in the lowest tertiles of WHR (<0.873) and highest tertile of insulin had 4.30 times (95{\%} CI = 1.17 to 15.70) the risk. By contrast, the association between leptin levels and prostate cancer risk was not statistically significant. Conclusion: Our results suggest that serum insulin levels may influence the risk of prostate cancer in Chinese men. Further research, especially prospective studies, is needed to confirm these findings in high-risk populations and to clarify the underlying mechanisms involved.",
author = "Hsing, {Ann W.} and {Chua, Jr.}, {Streamson C.} and Gao, {Yu Tang} and Elisabeth Gentzschein and Lilly Chang and Jie Deng and Stanczyk, {Frank Z.}",
year = "2001",
month = "5",
day = "16",
language = "English (US)",
volume = "93",
pages = "783--789",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Prostate cancer risk and serum levels of insulin and leptin

T2 - A population-based study

AU - Hsing, Ann W.

AU - Chua, Jr., Streamson C.

AU - Gao, Yu Tang

AU - Gentzschein, Elisabeth

AU - Chang, Lilly

AU - Deng, Jie

AU - Stanczyk, Frank Z.

PY - 2001/5/16

Y1 - 2001/5/16

N2 - Background: In a previous study of Chinese men, we found that men with a higher waist-to-hip ratio (WHR) have a higher prostate cancer risk. Because leptin and insulin are related to body fat distribution, we examined whether leptin and insulin were associated with prostate cancer risk. Methods: Blood samples were collected from 128 case patients with incident prostate cancer and from 306 healthy control subjects randomly selected from residents of Shanghai, China. Epidemiologic information and anthropometric measurements were collected in personal interviews. Serum leptin, insulin, and sex hormone levels were measured by radioimmunoassay, and insulin-like growth factor-I (IGF-I) was measured by enzyme-linked immunosorbent assay. Multiple logistic regression analyses were used to estimate odds ratios for prostate cancer in relation to serum insulin and leptin levels. All statistical tests were two-sided. Results: After adjustment for body mass index, WHR, IGF-I, and sex hormone levels, higher serum insulin levels were associated with a statistically significantly elevated risk of prostate cancer (P<.001). Men in the highest tertile of insulin levels had a 2.56-fold (95% confidence interval [CI] = 1.38 to 4.75) risk of prostate cancer compared with men in the lowest tertile. Regardless of the tertile level of WHR, higher serum insulin levels were associated with an increased risk of prostate cancer: Men in the highest tertiles of WHR (>0.900) and insulin (>8.83 μU/mL) had 8.55 times (95% CI = 2.80 to 26.10) the prostate cancer risk of men in the lowest tertiles of both, and those in the lowest tertiles of WHR (<0.873) and highest tertile of insulin had 4.30 times (95% CI = 1.17 to 15.70) the risk. By contrast, the association between leptin levels and prostate cancer risk was not statistically significant. Conclusion: Our results suggest that serum insulin levels may influence the risk of prostate cancer in Chinese men. Further research, especially prospective studies, is needed to confirm these findings in high-risk populations and to clarify the underlying mechanisms involved.

AB - Background: In a previous study of Chinese men, we found that men with a higher waist-to-hip ratio (WHR) have a higher prostate cancer risk. Because leptin and insulin are related to body fat distribution, we examined whether leptin and insulin were associated with prostate cancer risk. Methods: Blood samples were collected from 128 case patients with incident prostate cancer and from 306 healthy control subjects randomly selected from residents of Shanghai, China. Epidemiologic information and anthropometric measurements were collected in personal interviews. Serum leptin, insulin, and sex hormone levels were measured by radioimmunoassay, and insulin-like growth factor-I (IGF-I) was measured by enzyme-linked immunosorbent assay. Multiple logistic regression analyses were used to estimate odds ratios for prostate cancer in relation to serum insulin and leptin levels. All statistical tests were two-sided. Results: After adjustment for body mass index, WHR, IGF-I, and sex hormone levels, higher serum insulin levels were associated with a statistically significantly elevated risk of prostate cancer (P<.001). Men in the highest tertile of insulin levels had a 2.56-fold (95% confidence interval [CI] = 1.38 to 4.75) risk of prostate cancer compared with men in the lowest tertile. Regardless of the tertile level of WHR, higher serum insulin levels were associated with an increased risk of prostate cancer: Men in the highest tertiles of WHR (>0.900) and insulin (>8.83 μU/mL) had 8.55 times (95% CI = 2.80 to 26.10) the prostate cancer risk of men in the lowest tertiles of both, and those in the lowest tertiles of WHR (<0.873) and highest tertile of insulin had 4.30 times (95% CI = 1.17 to 15.70) the risk. By contrast, the association between leptin levels and prostate cancer risk was not statistically significant. Conclusion: Our results suggest that serum insulin levels may influence the risk of prostate cancer in Chinese men. Further research, especially prospective studies, is needed to confirm these findings in high-risk populations and to clarify the underlying mechanisms involved.

UR - http://www.scopus.com/inward/record.url?scp=0035897513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035897513&partnerID=8YFLogxK

M3 - Article

C2 - 11353789

AN - SCOPUS:0035897513

VL - 93

SP - 783

EP - 789

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 10

ER -